NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today changes and new appointments in its clinical and regulatory groups together with the departure of Brian Schwartz, MD, Chief Medical Officer, who will be leaving the Company as of July 11th to pursue other opportunities. His responsibilities as CMO will be assumed by Jonathan Lewis, MD, PhD, Chief Executive Officer.
